申请人:Ede J Nicholas
公开号:US20060094902A1
公开(公告)日:2006-05-04
In the present specification we describe a new class of compounds, designed to modulate the ability of blood vessels to synthesize NO from L-arginine. In particular we have identified novel compounds which enhance the entry of L-arginine into cells. These compounds improve endothelial function, and thereby have the potential to retard the progression of vascular disease in conditions such as hypertension, heart failure and diabetes. This new class of drugs may also have other potentially, relevant pharmacological actions, including anti-hypertensive and anti-anginal actions.
在本说明书中,我们描述了一种新的化合物类,旨在调节血管从L-精氨酸合成NO的能力。特别是,我们已经确定了一些新的化合物,可以增强L-精氨酸进入细胞的能力。这些化合物可以改善内皮功能,从而有潜力延缓高血压、心力衰竭和糖尿病等情况下血管疾病的进展。这种新型药物类别还可能具有其他潜在的药理作用,包括降压和抗心绞痛作用。